Professional · Investor meetups
Frenelle Private Investor Briefing
Mon, Nov 2 · 17:30 –
19:30
19:30
Fleming’s Prime Steakhouse & Wine BarFleming’s Prime Steakhouse & Wine Bar
Dear Investors, Frenelle is developing next-generation long-acting injectable therapeutics using its proprietary FarosTM drug-delivery platform. Its lead program, FRN01, is a 30-day subcutaneous buprenorphine injection being developed for Opioid Use Disorder. Join Opus8 and New...
Heat level
Heat level
Intel Contribs